Back to results

University of Cambridge

Identification of therapeutic targets and dependencies in ZNF703-amplified breast cancer

Abstract

dc:description.abstract

Focal amplifications of the chromosome 8p11.23, likely precipitated by oestrogen-induced chromosomal instability, are recurrent in 15% of breast cancer, defines the IntClust6 subtype, and portends poor prognosis with high risk of late relapse and chemotherapy resistance. ZNF703 is the most frequently amplified gene and the putative driver oncogene within this locus, though mechanisms are poorly understood. To identify therapeutic vulnerabilities for ZNF703-amplified breast cancers, wholegenome CRISPR-Cas9 screens were performed in isogenic cell lines with modulated ZNF703 expression alongside ZNF703-amplified cells. Here we report that ZNF703 amplification is synthetic lethal with loss of OTUD5, a regulator of DNA double strand break repair and interferon signalling. Furthermore, ZNF703 overexpression favours error-free repair of CRISPR-Cas9-induced double strand breaks and confers increased dependency on homologous recombination. Interactomic and transcriptomic profiling suggests ZNF703 binds to transcriptional repressors and interferon-related transcription factors, resulting in downregulation of interferon response. Notably, underexpression of interferon response genes is associated with dependency on OTUD5 and BRCA1. Together, these findings propose that ZNF703 facilitates cell growth under chromosomal instability, and antagonism of this function by OTUD5 loss represents a promising therapeutic strategy.

Degree

thesis:*
Name dc:type.qualificationname
Doctor of Philosophy (PhD)
Level dc:type.qualificationlevel
Doctoral
Grantor dc:publisher.institution
University of Cambridge
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lui, Allan
Advisors dc:contributor.advisor
  • Brenton, James
  • Caldas, Carlos

Subjects

dc:subject × 1

Rights

dc:rights
Language dc:language
eng

Identifiers

dc:identifier.*
Author Identifier
0000-0001-7624-3437
OAI identifier oai:identifier
oai:www.repository.cam.ac.uk:1810/393117

Chain of custody

source
Harvested from
Cambridge University
Base URL
api.repository.cam.ac.uk/server/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
related terms
citation

Lui, Allan. Identification of therapeutic targets and dependencies in ZNF703-amplified breast cancer. Doctoral thesis, University of Cambridge, 2024. https://doi.org/10.17863/CAM.123573